What’s Behind The Jump In ImmunityBio Stock?

All NewsFebruary 18, 2026

ImmunityBio shares are higher on Wednesday after the European Commission authorized one of its treatments for bladder cancer carcinoma.

Importance Rank:

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

What’s Behind The Jump In ImmunityBio Stock?

The UCW Newswire : Financial, Business and Tech News

Recent Headlines

Morgan Stanley says SpaceX stock is now cheaper than the S&P 500

50-year-old iconic theme park closing down forever

Walmart is selling an outdoor heater capable of warming an 18-foot area for $90

Walmart is selling a 4-person rocking patio set with a large coffee table for $105

Bloom Energy wins abroad while Texas turns against data centers